Because c-MET DNA amplification was relatively rare in HCC samples (8/348 of HCC patients in TCGA dataset according to cBioPortal dataset), other unrevealed mechanisms likely help sustain c-MET activation. This evidence concerns the gene MET and hepatocellular carcinoma.